Lumigan and Latisse
Lumigan is bimatoprost .03% and was developed to treat glaucoma by Allergan. Glaucoma patients noticed an intersesting side effect to Lumigan, they started to see in increase in the length and thickness of their eyelashes. Soon regulatory approval was approved for Bimatoprost .03% to be used to grow longer and thicker eyelashes. Latisse was branded for the specific use of eyelash treatment.
Cost conscience consumers realize that Lumigan and Latisse are the exact same medication manufactured by the same laboratory, Allergan. However, Lumigan is priced much lower than Latisse due to marketing strategies. Hairsave.com supplies Allergan brand Lumigan at substantial savings. Order Lumigan (Latisse), quality assured name brand medication at wholesale prices.
|